Liberia vs Sierra Leone: Population requiring preventive chemotherapy for schistosomiasis
Liberia
2.49 million
in 2024
Sierra Leone
1.94 million
in 2024
Liberia rank
28th
Sierra Leone rank
31st
Population requiring preventive chemotherapy for schistosomiasis over time
- Liberia
- Sierra Leone
How they compare
Liberia currently reports 2.49 million against 1.94 million in Sierra Leone, a difference of 552,490.
That makes Liberia's figure about 1.3 times Sierra Leone's.
The two have swapped places 7 times across 15 shared years of data; in 2010 it was Sierra Leone ahead.
Liberia ranks 28th and Sierra Leone ranks 31st of 52 countries.
Sierra Leone has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.12 million | 1.51 million | 383,124 | Sierra Leone |
| 2020s | 1.42 million | 1.80 million | 381,599 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Liberia or Sierra Leone?
- Liberia, at 2.49 million against 1.94 million in Sierra Leone as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Liberia and Sierra Leone?
- 552,490, with Liberia ahead.
- How many years of comparable data are there for Liberia and Sierra Leone?
- 15 years are reported by both, from 2010 to 2024.
- How do Liberia and Sierra Leone rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Liberia ranks 28th and Sierra Leone ranks 31st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.